New Treatment Approaches for Leukemias Emerging From Early Clinical Trials
New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy
Genasense Added To Chemo Improves Responses in CLL
Blacks, Whites Have Same Contralateral Breast Cancer Risk While On Tamoxifen
Of Smokers Screened With CT In Study, 7% Have Lung Cancer
Insulin For Diabetes Increases Risk Of Colorectal Cancer
NCI-Approved Clinical Trials
Trending Stories
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- What are you reading in 2023?
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence